Delivery Order SPE2DB20D2104-SPE2DB23FT87E
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,081.74 firm-fixed-price delivery order is for the supply of 4,559,542 units of 4 mg naloxone hydrochloride nasal spray. The contract has an ultimate completion date of January 10, 2023 and is not associated with any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,357.92, is a delivery order to provide 4,565,123,305 units of the drug Naloxone HCL 4 mg Nasal Spray. The contract has an ultimate completion date of July 12, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,271.05, is for the delivery of 4,562,300 units of Naloxone HCL 4 mg nasal spray. This is a Firm Fixed Price Delivery Order contract that runs through September 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,780.87 Firm Fixed Price Delivery Order is for the supply of 4,562,158,402 units of Naloxone HCl 4 mg Nasal Spray. The award has an ultimate completion date of September 14, 2023 and was made on September 13, 2023. There was no set-aside designation for this contract. AmerisourceBergen holds a $999,999,999...
- This federal contract award, valued at $1,755.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used in the treatment of opioid overdose. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $4,649.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,421,527 units of Naloxone Hydrochloride 4 mg Nasal Spray, a critical medication used to reverse opioid overdoses. This is a firm-fixed price delivery order contract with a completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $6,498.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,263,195 units of Naloxone HCl 4 mg Nasal Spray, a medication used to reverse opioid overdose. This is a firm fixed-price delivery order contract with an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $9,517.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,558,422,780 units of 4 mg Naloxone HCl Nasal Spray, a critical medication used to treat opioid overdoses. The contract is a Firm Fixed Price Delivery Order with a completion date of September 13, 2022. Amerisourcebergen holds a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,367,200 units of Naloxone HCL 4 mg Nasal Spray. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,950.71 and an ultimate completion date of August 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,298.28, is for the delivery of 4,563,004,099 units of Naloxone HCL 4 mg Nasal Spray by December 6, 2023. This contract is a Firm Fixed Price Delivery Order and was not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has been...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT87EDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,473.26 firm fixed-price delivery order is for the supply of 4,561,156,074 units of 4 mg Naloxone HCl nasal spray. The contract has a completion date of June 7, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable streamlined government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/6/23 |